Back to Search Start Over

AstriVax awarded é¼3m to develop therapeutic vaccine for hepatitis

Source :
PharmaTimes. December 15, 2023
Publication Year :
2023

Abstract

The funding builds on AstriVax's 30m in seed funding for its vaccine platform AstriVax has announced that it has been awarded a total of 3m in funding from Flanders Innovation [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
PharmaTimes
Accession number :
edsgcl.776361372